NCT07215481View on ClinicalTrials.gov

Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Parkinson's Disease (PD)
Interventions
DEVICE

Shame Control (Baseline)

Participant's device (Boston Scientific Vercise Genus neurostimulator) is turned off for 45 minutes.

DEVICE

Standard of Care Deep Brain Stimulation

Participant's device (Boston Scientific Vercise Genus neurostimulator) is turned 'ON' for 45 minutes using a configuration and amplitude determined as standard of care by the clinician.

DEVICE

Illumina 3D Deep Brain Stimulation

Participant's device (Boston Scientific Vercise Genus neurostimulator) is turned 'ON' for 45 minutes using a configuration and amplitude determined by the automated Illumina 3D algorithm.

DEVICE

Illumina 3D Deep Brain Stimulation Reduced Amplitude

Participant's device (Boston Scientific Vercise Genus neurostimulator) is turned 'ON' for 45 minutes using a configuration and amplitude determined by the automated Illumina 3D algorithm but at a reduced stimulation amplitude.

DEVICE

Illumina 3D Deep Brain Stimulation Higher Amplitude

Participant's device (Boston Scientific Vercise Genus neurostimulator) is turned 'ON' for 45 minutes using a configuration and amplitude determined by the automated Illumina 3D algorithm but at a higher stimulation amplitude.

Trial Locations (1)

94305

Stanford Neuroscience Health Clinic, Stanford

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Stanford University

OTHER

NCT07215481 - Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease | Biotech Hunter | Biotech Hunter